(TSLA) Tesla - Overview
Stock: Electric Vehicles, Energy Storage, Solar Panels, Superchargers
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 50.4% |
| Relative Tail Risk | -7.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.39 |
| Alpha | -20.71 |
| Character TTM | |
|---|---|
| Beta | 2.194 |
| Beta Downside | 2.047 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.77% |
| CAGR/Max DD | 0.52 |
Description: TSLA Tesla January 28, 2026
Tesla, Inc. (NASDAQ:TSLA) designs, manufactures, and sells electric vehicles (EVs) and provides energy generation and storage solutions across the United States, China, and other international markets. The company operates two primary segments: Automotive-covering EV sales, regulatory-credit sales, after-sales services, Supercharger network, financing, leasing, insurance, and used-vehicle operations; and Energy Generation & Storage-offering solar panels, solar roofs, Powerwall/Powerpack/Megapack systems, installation, leasing, and related services.
Key recent metrics: • Q4 2023 vehicle deliveries reached 422,000 units, a 13% YoY increase, driven largely by Model Y production in Shanghai and Austin. • Automotive gross margin expanded to 21.5% in Q4 2023, up from 19.8% a year earlier, reflecting higher mix of higher-margin models and cost efficiencies in battery sourcing. • Energy storage deployments grew 38% YoY in 2023, with Megapack installations surpassing 6 GWh, supported by rising utility-scale renewable-integration demand. Sector drivers include accelerating global EV adoption (global EV stock projected to hit 45 million by 2027) and declining lithium-ion battery costs, which fell an average of 12% year-over-year in Q4 2023.
For a deeper quantitative assessment, explore the ValueRay dashboard for Tesla’s latest valuation and risk metrics.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 3.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.58 > 1.0 |
| NWC/Revenue: 38.94% < 20% (prev 30.24%; Δ 8.71% < -1%) |
| CFO/TA 0.11 > 3% & CFO 14.75b > Net Income 3.79b |
| Net Debt (-8.14b) to EBITDA (11.76b): -0.69 < 3 |
| Current Ratio: 2.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.54b) vs 12m ago 0.63% < -2% |
| Gross Margin: 18.03% > 18% (prev 0.18%; Δ 1785 % > 0.5%) |
| Asset Turnover: 72.98% > 50% (prev 80.03%; Δ -7.05% > 0%) |
| Interest Coverage Ratio: 16.62 > 6 (EBITDA TTM 11.76b / Interest Expense TTM 338.0m) |
Altman Z'' 3.72
| A: 0.27 (Total Current Assets 68.64b - Total Current Liabilities 31.71b) / Total Assets 137.81b |
| B: 0.28 (Retained Earnings 39.00b / Total Assets 137.81b) |
| C: 0.04 (EBIT TTM 5.62b / Avg Total Assets 129.94b) |
| D: 0.72 (Book Value of Equity 39.37b / Total Liabilities 54.94b) |
| Altman-Z'' Score: 3.72 = AA |
Beneish M -2.45
| DSRI: 1.07 (Receivables 4.58b/4.42b, Revenue 94.83b/97.69b) |
| GMI: 0.99 (GM 18.03% / 17.86%) |
| AQI: 2.07 (AQ_t 0.21 / AQ_t-1 0.10) |
| SGI: 0.97 (Revenue 94.83b / 97.69b) |
| TATA: -0.08 (NI 3.79b - CFO 14.75b) / TA 137.81b) |
| Beneish M-Score: -2.45 (Cap -4..+1) = BBB |
What is the price of TSLA shares?
Over the past week, the price has changed by -4.48%, over one month by -5.05%, over three months by -7.80% and over the past year by +9.83%.
Is TSLA a buy, sell or hold?
- StrongBuy: 14
- Buy: 7
- Hold: 16
- Sell: 3
- StrongSell: 7
What are the forecasts/targets for the TSLA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 418.8 | 1.9% |
| Analysts Target Price | 418.8 | 1.9% |
| ValueRay Target Price | 447.2 | 8.8% |
TSLA Fundamental Data Overview February 07, 2026
P/E Forward = 192.3077
P/S = 15.7181
P/B = 18.5486
P/EG = 6.396
Revenue TTM = 94.83b USD
EBIT TTM = 5.62b USD
EBITDA TTM = 11.76b USD
Long Term Debt = 6.58b USD (from longTermDebt, last quarter)
Short Term Debt = 1.64b USD (from shortTermDebt, last quarter)
Debt = 8.38b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -8.14b USD (from netDebt column, last quarter)
Enterprise Value = 1496.99b USD (1490.50b + Debt 8.38b - CCE 1.89b)
Interest Coverage Ratio = 16.62 (Ebit TTM 5.62b / Interest Expense TTM 338.0m)
EV/FCF = 240.7x (Enterprise Value 1496.99b / FCF TTM 6.22b)
FCF Yield = 0.42% (FCF TTM 6.22b / Enterprise Value 1496.99b)
FCF Margin = 6.56% (FCF TTM 6.22b / Revenue TTM 94.83b)
Net Margin = 4.00% (Net Income TTM 3.79b / Revenue TTM 94.83b)
Gross Margin = 18.03% ((Revenue TTM 94.83b - Cost of Revenue TTM 77.73b) / Revenue TTM)
Gross Margin QoQ = 20.12% (prev 17.99%)
Tobins Q-Ratio = 10.86 (Enterprise Value 1496.99b / Total Assets 137.81b)
Interest Expense / Debt = 1.01% (Interest Expense 85.0m / Debt 8.38b)
Taxrate = 27.52% (325.0m / 1.18b)
NOPAT = 4.07b (EBIT 5.62b * (1 - 27.52%))
Current Ratio = 2.16 (Total Current Assets 68.64b / Total Current Liabilities 31.71b)
Debt / Equity = 0.10 (Debt 8.38b / totalStockholderEquity, last quarter 82.14b)
Debt / EBITDA = -0.69 (Net Debt -8.14b / EBITDA 11.76b)
Debt / FCF = -1.31 (Net Debt -8.14b / FCF TTM 6.22b)
Total Stockholder Equity = 78.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.92% (Net Income 3.79b / Total Assets 137.81b)
RoE = 4.83% (Net Income TTM 3.79b / Total Stockholder Equity 78.52b)
RoCE = 6.60% (EBIT 5.62b / Capital Employed (Equity 78.52b + L.T.Debt 6.58b))
RoIC = 4.73% (NOPAT 4.07b / Invested Capital 85.97b)
WACC = 13.93% (E(1490.50b)/V(1498.88b) * Re(14.0%) + D(8.38b)/V(1498.88b) * Rd(1.01%) * (1-Tc(0.28)))
Discount Rate = 14.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.67%
[DCF Debug] Terminal Value 56.74% ; FCFF base≈5.16b ; Y1≈4.59b ; Y5≈3.83b
Fair Price DCF = 10.92 (EV 32.84b - Net Debt -8.14b = Equity 40.98b / Shares 3.75b; r=13.93% [WACC]; 5y FCF grow -13.76% → 2.90% )
EPS Correlation: -71.21 | EPS CAGR: -18.36% | SUE: 0.31 | # QB: 0
Revenue Correlation: 52.52 | Revenue CAGR: 7.85% | SUE: 0.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.41 | Chg30d=-0.028 | Revisions Net=+0 | Analysts=22
EPS current Year (2026-12-31): EPS=2.07 | Chg30d=-0.132 | Revisions Net=-9 | Growth EPS=+24.8% | Growth Revenue=+8.8%
EPS next Year (2027-12-31): EPS=2.87 | Chg30d=-0.215 | Revisions Net=-6 | Growth EPS=+38.4% | Growth Revenue=+18.9%